Related Experiment Video
Updated: Oct 21, 2025
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
896
A possible follow-up method for diabetic heart failure patients
1University of Health Sciences, Keçiören Education and Training Hospital, Ankara, Turkey.
International Journal of Clinical Practice
|September 5, 2021
Summary
Lens vacuoles may indicate changes in diabetic heart failure and treatment effectiveness. Monitoring these vacuoles could offer a new method for tracking patient progress and therapeutic response.
Area of Science:
- Ophthalmology
- Cardiology
- Endocrinology
Background:
- Plasma osmolarity is crucial for bodily functions and is linked to aqueous humor osmolarity.
- Lens vacuoles can form due to osmotic shifts, potentially reflecting systemic osmolarity changes.
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) treat heart failure via osmotic diuresis without altering plasma osmolarity.
Purpose of the Study:
- To investigate if lens vacuole changes can monitor diabetic heart failure.
- To determine if lens vacuoles can track the efficacy of SGLT2i treatment in diabetic heart failure patients.
Main Methods:
- Literature search conducted on Web of Science, PubMed, and Scopus databases.
- Included studies focused on osmolarity, diabetes, transient receptor potential vanilloid channels, diabetic heart failure, and lens vacuoles.
- Search updated to May 2021.
Main Results:
- SGLT2i benefits in heart failure are linked to their osmotic effects, influencing various bodily mechanisms.
- A lack of observable osmolarity changes may hinder the beneficial effects of SGLT2i in heart failure.
- A practical, observable method for monitoring these changes is needed.
Conclusions:
- Lens vacuoles present a potential biomarker for monitoring diabetic heart failure.
- The presence or absence of lens vacuoles may indicate treatment response to SGLT2i in this patient population.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
59
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
59
01:30Heart Failure VII: Nursing Interventions
194
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
194
01:30Heart Failure V: Medical Management
52
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
01:30Heart Failure IV: Classification and Diagnostic Evaluation
74
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74
01:30Cardiomyopathy II: Dilated Cardiomyopathy
83
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
83
01:29Cardiomyopathy V: Interprofessional Care
69
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
69